Results 131 to 140 of about 17,697 (207)

Development of a New Positron Emission Tomography Imaging Radioligand Targeting RIPK1 in the Brain and Characterization in Alzheimer's Disease

open access: yesAdvanced Science
Targeting receptor‐interacting protein kinase 1 (RIPK1) has emerged as a promising therapeutic stratagem for neurodegenerative disorders, particularly Alzheimer's disease (AD).
Ping Bai   +20 more
doaj   +1 more source

RIPK1 inhibition mitigates neuroinflammation and rescues depressive-like behaviors in a mouse model of LPS-induced depression

open access: yesCell Communication and Signaling
Background Depression is often linked to inflammation in the brain. Researchers have been exploring ways to reduce this inflammation to improve depression symptoms.
Qichao Gong   +12 more
doaj   +1 more source

Serum Level of RIPK1/3 Correlated With the Prognosis in ICU Patients With Acute Ischemic Stroke

open access: yesImmunity, Inflammation and Disease
Background Acute ischemic stroke (AIS) is a common cerebrovascular disease with high mortality. AIS patients in the intensive care unit (ICU) often have severe conditions that require close monitoring and timely treatment.
Jianhong Dong, Xinli Xiong
doaj   +1 more source

RIPK1 prevents aberrant ZBP1-initiated necroptosis

open access: yesOncotarget, 2016
Berghe, Tom Vanden, Kaiser, William J.
openaire   +2 more sources

Necroptotic signaling orchestrates glioblastoma malignancy and potentiates temozolomide response. [PDF]

open access: yesCell Death Dis
Li Y   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy